Disease spotlight: Duchenne muscular dystrophy (DMD)
Views & Analysis
News
Are Makary's priority review vouchers about to be canned?
Reports are emerging that the national priority voucher scheme launched by former FDA chief Marty Makary may be heading for the scrap heap.
Sales & Marketing
Sponsored
Securing your ROI: Turning post-acquisition integration into...
Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
Deep Dive
Why pharma needs honest patient dialogue
Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience.
Sales & Marketing
Sponsored
Are Insights leaders seeing real commercial value from AI ad...
Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.
Patients
Patients not just at the table, but creating their own: In c...
Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC discusses why is patient inclusion is not the same as patient leadership.
Digital
Sponsored
From Pilot to Practice: Insights into AI Adoption, Impact, a...
Read Medidata’s 2nd annual survey, 'The State of AI in Clinical Trials. From Pilot to Practice: Insights into AI Adoption, Impact, and Expectations'.
Partner Content
Partner Content
PMi Awards 2026: innovation, connection and a changing indus...
One of the things I enjoyed most about this year’s PM Society PMi Awards was the sheer breadth of the community in the room.
Event
31st Edition Strategic Project & Portfolio Management for Ph...
The Marcus Evans 31st Edition Strategic Project & Portfolio Management for Pharma conference, for European pharmaceutical PMO and portfolio leaders.
Category :
Views & Analysis
/